RAPT Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights

    NEXT STORY
    Study Shows Only 40 Percent of Patients with Metastatic Colon Cancer Receive Guideline-Recommended Biomarker Testing
    PREV STORY
    Athenex Announces Details of Investor Event and Webcast at SABCS on December 13, 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences

    author_avatar
    NASDAQ Market News

    Protech Home Medical Announces Date and Time for Q3 2020 Conference Call and Audio Webcast

    author_avatar
    NASDAQ Market News

    Mateon Therapeutics Announces Termination of FOCUS Study in Ovarian Cancer and Restructuring to Prioritize OXi4503 for AML

    Company to terminate FOCUS study due to lack of clear efficacy signal in the ...

    author_avatar
    NASDAQ Market News